Skip to main content
. 2015 Sep 22;10(9):e0138340. doi: 10.1371/journal.pone.0138340

Fig 4. Plasma concentration of 25-hydroxyvitamin D3 at baseline, week 4, 8 and 12 after initiation of treatment in TB patients in the four intervention arms.

Fig 4

The groups receiving vitD3 supplementation (vitD3 and PBA+vitD3-groups) exhibited significantly higher concentrations of plasma 25-hydroxyvitamin D3 at week 4, 8 and 12 intervals compared to placebo after initiation of therapy (p<0.000 for all).